 | Fri, Aug 26, 2022 | | | |
|
|
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Pfizer and Moderna asked the Food and Drug Administration this week to authorize their updated booster shots that target the omicron BA.5 subvariant. The new boosters are expected to roll out to the public after Labor Day weekend. The FDA and CDC believe the updated shots will provide more durable protection against infection and mild illness from the dominant omicron subvariant. But some scientists are calling for the FDA and CDC to wait until there's human data that clearly demonstrates the updated boosters are better than the currently available shots. So far, the public has only seen data on the new shots from mouse studies. The vaccine manufacturers, meanwhile, are turning against each other. Moderna sued Pfizer and BioNTech on Friday, alleging the companies copied its mRNA technology. And Dr. Anthony Fauci, the nation's top infectious disease expert, is stepping down at the end of the year after more than 50 years of public service. Fauci became the face of the U.S. response to the Covid-19 pandemic. He is the only senior health official to serve in both the Trump and Biden administrations. Feel free to send any tips, suggestions, story ideas and data to me at spencer.kimball@nbcuni.com. |
|
|
Pfizer and its German partner BioNTech on Monday asked the Food and Drug Administration to authorize Covid booster shots that target the omicron BA.4 and BA.5 subvariants for people ages 12 and older. Public health officials hope the new shots will provide broader and more durable protection against infection and mild illness. However, some experts are calling for the FDA and the vaccine companies to present more data on the new shots before they receive authorization. |
|
|
The nation's top infectious disease expert, Dr. Anthony Fauci, plans to step down from his roles running the National Institute of Allergy and Infectious Diseases and advising the White House as its chief medical advisor at the end of the year, he announced Monday.
Fauci has become a household fixture during the Covid-19 pandemic, battling back misinformation — sometimes from the highest levels of government. His steadfast commitment to science, challenging former President Donald Trump on everything from the use of hydroxychloroquine to mask mandates, made him a quasi-celebrity in the process |
|
|
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. The lawsuit, which seeks undetermined monetary damages, was being filed in U.S. District Court in Massachusetts and the Regional Court of Dusseldorf in Germany, Moderna said in a news release on Friday. "We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the Covid-19 pandemic," Moderna Chief Executive Stephane Bancel said in the statement. |
|
|
In 2003, 47 people across six Midwestern states caught monkeypox from pet prairie dogs that were infected after they were housed with rodents imported from Ghana, Africa.
Today's outbreak, which has already infected more than 14,100 people in the U.S. and more than 41,000 across the globe, is spreading mostly through close human contact among gay and bisexual men. But scientists reported the first presumed human-to-pet transmission in a dog in France this month, prompting U.S. and global health officials to step up warnings to ensure the virus doesn't spread to other pets and animals. The recommendation stems from concerns that monkeypox could spill into wildlife or rodent populations as the human outbreak grows, allowing the virus to pass back-and-forth between humans and animals and giving the virus a permanent foothold in countries where it hasn't historically circulated. |
|
|
Amazon is reportedly battling CVS Health and UnitedHealth Group to acquire home care and data analytics firm Signify Health, just a month after beating out CVS to buy primary-care provider One Medical. At the same time, Amazon health chief Neil Lindsay has decided to pull the plug on the company's own virtual care program, Amazon Care, at the end of the this year. It's a sign that the company has decided to buy rather than try to build a health services platform from scratch. If Lindsay prevails on the two deals, it could make Amazon real contender in health services. Until now, it have been more of an also-ran. |
|
|
Americans are dealing with risk fatigue surrounding infectious diseases like Covid, polio and monkeypox. Many are already affected by Covid fatigue, but other diseases circulating are adding an extra level of anxiety. Here's what to know about Covid, polio and monkeypox, according to a physician, and tips for how to deal with the stress provided by a clinical psychologist. |
|
|
|
Tidak ada komentar:
Posting Komentar